Anemia Drug Feraheme Assigned Boxed Warning by FDA

The Food and Drug Administration has assigned a boxed warning – the highest level there is – for Feraheme (ferumoxytol), an anti-anemia drug. Feraheme has been found to increase the risk of “serious, potentially fatal allergic reactions” specifically for “patients who have had an allergic reaction to any intravenous (IV) iron replacement product” according to…

Read More

What is in Your Weight Loss Supplements?

As of 2013, the U.S. segment of the global market for weight loss products is more than $60 billion, with $2.69 billion for meal replacements and weight loss supplements. About half of American adults were trying to lose weight, according to a Marketdata Enterprises Inc. report. Millions of Americans take weight loss supplements in an…

Read More

Zofran Birth Defects Lawsuits

Zofran (Ondansetron) is a drug manufactured by GlaxoSmithKline, which was approved by the FDA in 1991 to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. Ondansetron is a 5-HT3 receptor antagonist, which blocks the action of serotonin in the brain which is thought to cause vomiting and nausea. After Zofran was…

Read More